A single-dose study of IBIO-600 in healthy overweight or obese adults
Part of Hormones & metabolism clinical trials.
This trial tests a single dose of an experimental treatment called IBIO-600 to see if it's safe and how it works in overweight or obese adults. It's for people who are generally healthy and have a stable weight, without diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 to 65 and in good general health.
- Your body mass index (BMI) must be between 27.0 and 34.9 — that's considered overweight or mildly obese.
- Your weight must have stayed about the same (no more than 5% change) in the last 3 months.
- You cannot have diabetes (type 1 or 2).
- You must be a non-smoker and have not used nicotine products (like cigarettes or vaping) for at least 1 month before starting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication called IBI3032 in healthy people and those with overweight or obesity. It aims to see if the drug is safe and how the body processes it.
This study tests an investigational drug called IBI3040 in healthy volunteers and in people who are overweight or obese. It aims to see if the drug is safe and how it affects body weight.
This trial tests an investigational drug called BI 3034701 to see if it helps people lose weight. It is for adults who are obese or overweight with at least one weight-related health problem.
This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This trial tests different doses of a new medicine in healthy Japanese people and those with obesity or overweight. It aims to see how well the body handles the drug and if it is safe.
Hear when a new Overweight , Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.